Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a vaccine, chemotherapy and an immunotherapy for cancer that has spread from where it started (MAGE Vaccine Trial)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Secondary cancers, Stomach cancer

Status:

Closed

Phase:

Phase 1/2

Details

This trial is looking at 3 vaccines with standard treatment for non small cell lung cancer, oesophageal cancer and gastro oesophageal junction cancer that has spread from where it started.

Cancer Research UK supports this trial.

Recruitment start: 15 October 2021

Recruitment end: 2 April 2024

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Fiona Blackhall

Supported by

Cancer Research UK

Other information

This is Cancer Research UK trial number CRUKD/20/001.

Last reviewed: 27 Mar 2025

CRUK internal database number: 17225

Help and support